We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




New Products Streamline Molecular Biological and Molecular Genetic Research

By LabMedica International staff writers
Posted on 18 May 2009
Researchers using molecular biological and molecular genetic techniques will benefit from the introduction of a series of new products designed to support investigators in such diverse fields as cancer research, biomarker identification, target validation, and drug development.

The common denominator is the necessity of working with DNA and RNA. More...
For research involving DNA Qiagen (Venlo, The Netherlands) has developed and is now placing on the market two dedicated kits for real-time PCR. The QuantiFast Multiplex RT-PCR kit enables one-step applications on both standard and fast real-time cyclers without requiring optimization. The Rotor-Gene Kit allows detection of up to four targets per tube and includes optimized protocols for Qiagen's Rotor-Gene Q instrument. These fast real-time PCR technologies provide speed and accuracy not only on fast cyclers, but also on standard cyclers. For applications such as siRNA gene silencing, these kits allow the real-time PCR workflow to be streamlined by eliminating the need for RNA purification while permitting analysis of multiple targets in one tube.

To speed the preparation of nuclear materials from tissue samples Qiagen suggests using the new TissueLyser LT. This instrument uses bead mill technology to break-up tissue and provide fast access to DNA, RNA, and proteins. This small, easy-to-operate bead mill can process up to 12 samples, fresh or frozen, in parallel using the carousel adaptor. The 12-sample format has the additional benefit of seamless integration with other QIAGEN automated instruments.

"QIAGEN offers the broadest portfolio of products on the market for manual and automated gene expression and function analysis,” said Dr. Annette Tietze, senior global product manager at Qiagen. "Our customers who perform real-time PCR and gene silencing are able to achieve success in all steps of their experiments without the need for optimization. Our newest products are helping customers standardize experiments, save time and cost due to ease of use, and provide reliable automation of higher throughput experiments.”

Related Links:
Qiagen



Platinum Member
ADAMTS-13 Protease Activity Test
ATS-13 Activity Assay
Verification Panels for Assay Development & QC
Seroconversion Panels
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
ESR Analyzer
miniiSED™
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.